Clinical evaluation of clopidogrel across the whole spectrum of indications: primary and secondary prevention of coronary artery disease

EI de Oliveira, DL Bhatt - European heart journal supplements, 2006 - academic.oup.com
Clopidogrel has been evaluated across the spectrum of secondary and primary prevention.
Initially, the CAPRIE trial randomized patients with recent myocardial infarction, ischemic …
被引用次数：5 相关文章

Clinical evaluation of clopidogrel across the whole spectrum of indications: primary and secondary prevention of coronary artery disease

EI de Oliveira, DL Bhatt - European Heart Journal Supplements, 2006 - elibrary.ru
Clopidogrel has been evaluated across the spectrum of secondary and primary prevention.
Initially, the CAPRIE trial randomized patients with recent myocardial infarction, ischemic …

[引用][C] Clinical evaluation of clopidogrel across the whole spectrum of indications: primary and secondary prevention of coronary artery disease

EI DE OLIVEIRA, DL BHATT - European heart journal …, 2006 - pascal-francis.inist.fr
Clinical evaluation of clopidogrel across the whole spectrum of indications : primary and
secondary prevention of coronary artery disease CNRS Inist Pascal-Francis CNRS Pascal …
[PDF] archive.org

[PDF][PDF] Clinical evaluation of clopidogrel across the whole spectrum of indications: primary and secondary prevention of coronary artery disease

EI de Oliveira, DL Bhatt - European Heart Journal Supplements, 2006 - scholar.archive.org
The humanitarian and economical impact of cardiovascular ischaemic events has lead to
extensive investigation in the field of atherothrombosis. Antiplatelet therapy has been a very …

[引用][C] Clinical evaluation of clopidogrel across the whole spectrum of indications: primary and secondary prevention of coronary artery disease

EI DE OLIVEIRA, DL BHATT - European heart journal …, 2006 - Oxford University Press